Glycodrive
Glycodrive, licence 80083652: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Blue Star Nutraceuticals Inc.
- NPN or DIN-HM
- 80083652
- Status
- Active licence
- Licence date
- 7 March 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 500 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lagerstroemia speciosa Source : Feuille Potency : 1.0 % Corosolic acid | 50.0 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Potency : 60.0 % 4-Hydroxyisoleucine | 250.0 mg | Not calculated |
| Panax ginseng Source : Racine et rhizome | 25.0 mg | Not calculated |
| Rosa roxburghii Source : Fruit | 25.0 mg | Not calculated |
| Vanadium Source : Sulfate de vanadyle | 182.0 mcg | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 500.0 mcg | 500 µg |
| Piper nigrum Source : Fruit Potency : 95.0 % Piperine | 5.0 mg | Not calculated |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Sodium R-(+)-Lipoate | 2.0 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 1.0 mcg | Not calculated |
| Panax ginseng Source : Racine | 1.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Acide fumarique, Cellulose microcristalline, Acide succinique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates. Helps the body to metabolize fats. Provides support for healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083652
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.